|
|

Wednesday, August 20, 2008
BioImagene Gets $26M In Series D Funding
Cupertino-based BioImagene, a developer of digital pathology products used in cancer diagnostics and for preclinical research, said Tuesday that the firm has raised $26M in a Series D funding round. The round was led by Burrill & Company. Other investors in the round included Ascension Health Ventures, National Healthcare Services, Artiman Ventures and ICCP Ventures. BioImagene's products are used for digital pathology.
posted on Wednesday, August 20, 2008 (Link to more information)
|
Sign up to receive updates via our daily email newsletter
|

Previous Issues
Tuesday, January 6, 2009
Monday, January 5, 2009
Friday, January 2, 2009
Wednesday, December 31, 2008
Monday, December 29, 2008
|